Thomas Gibbs

Thomas Gibbs is an experienced pharmaceutical executive with a diverse career spanning multiple leadership roles in the industry.1 He served as SVP and Chief Commercial Officer at Sunovion Pharmaceuticals from November 2019 to December 2021, leading commercial operations for the US, Canada, and Europe.1 During this time, he also held positions on the Board of Directors for Sunovion Pharmaceuticals in Canada and Europe.1

Currently, Gibbs is the EVP, Head of Lundbeck US / President Lundbeck, LLC., a position he has held since February 2023.1 Prior to his current role, he briefly served as Chief Executive Officer and GBL at Vectura Inc (US) from January 2022 to February 2023.1

Gibbs' career history includes notable positions such as:

• Executive Vice President and Chief Commercial Officer at Optinose (April 2019 - October 2019)1
• SVP / Head of General Medicines - US at Takeda (2015 - 2016)1
• Various leadership roles at Bristol-Myers Squibb, including Vice President of Worldwide Commercial Operations and Vice President of the HIV Franchise US Pharmaceuticals (2010 - 2015)1
• Vice President US Sales at Novartis (2007 - 2010)1

Throughout his career, Gibbs has demonstrated expertise in commercial operations, brand commercialization, and leadership within the pharmaceutical industry.1